Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma

被引：16
作者：
Carter, Stephanie J. [1 ]
Bernstein, Steven H. [1 ]
Friedberg, Jonathan W. [1 ]
Barr, Paul M. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Hematol & Oncol, Rochester, NY 14642 USA
来源：
LEUKEMIA RESEARCH | 2011年 / 35卷 / 11期
关键词：
NON-HODGKINS-LYMPHOMA; INDOLENT B-CELL; PHASE-II MULTICENTER; MANTLE CELL; REFRACTORY INDOLENT; CARINII-PNEUMONIA;
D O I：
10.1016/j.leukres.2011.07.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E223 / E224
页数：2
相关论文
共 10 条
[1]  
[Anonymous], BLOOD
[2]   OPPORTUNISTIC PULMONARY INFECTIONS WITH FLUDARABINE IN PREVIOUSLY TREATED PATIENTS WITH LOW-GRADE LYMPHOID MALIGNANCIES - A ROLE FOR PNEUMOCYSTIS-CARINII PNEUMONIA PROPHYLAXIS [J].
BYRD, JC ;
HARGIS, JB ;
KESTER, KE ;
HOSPENTHAL, DR ;
KNUTSON, SW ;
DIEHL, LF .
AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (02) :135-142
[3]   Optimal Use of Bendamustine in Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphomas, and Multiple Myeloma: Treatment Recommendations From an International Consensus Panel [J].
Cheson, Bruce D. ;
Wendtner, Clemens-Martin ;
Pieper, Angelika ;
Dreyling, Martin ;
Friedberg, Jonathan ;
Hoelzer, Dieter ;
Moreau, Philippe ;
Gribben, John ;
Knop, Stefan ;
Montillo, Marco ;
Rummel, Mathias .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (01) :21-27
[4]   Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: Results from a phase II multicenter, single-agent study [J].
Friedberg, Jonathan W. ;
Cohen, Philip ;
Chen, Ling ;
Robinson, K. Sue ;
Forero-Torres, Andres ;
La Casce, Ann S. ;
Fayad, Luis E. ;
Bessudo, Alberto ;
Camacho, Elber S. ;
Williams, Michael E. ;
Van der Jagt, Richard H. ;
Oliver, Jennifer W. ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) :204-210
[5]   Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma Results From a Multicenter Study [J].
Kahl, Brad S. ;
Bartlett, Nancy L. ;
Leonard, John P. ;
Chen, Ling ;
Ganjoo, Kristen ;
Williams, Michael E. ;
Czuczman, Myron S. ;
Robinson, K. Sue ;
Joyce, Robin ;
van der Jagt, Richard H. ;
Cheson, Bruce D. .
CANCER, 2010, 116 (01) :106-114
[6]   Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer [J].
Klippstein, A ;
Schneider, CP ;
Sayer, HG ;
Höffken, K .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (05) :316-319
[7]   Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma [J].
Ohmachi, Ken ;
Ando, Kiyoshi ;
Ogura, Michinori ;
Uchida, Toshiki ;
Itoh, Kuniaki ;
Kubota, Nobuko ;
Ishizawa, Kenichi ;
Yamamoto, Joji ;
Watanabe, Takashi ;
Uike, Naokuni ;
Choi, Ilseung ;
Terui, Yasuhito ;
Usuki, Kensuke ;
Nagai, Hirokazu ;
Uoshima, Nobuhiko ;
Tobinai, Kensei .
CANCER SCIENCE, 2010, 101 (09) :2059-2064
[8]   Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma [J].
Robinson, K. Sue ;
Williams, Michael E. ;
van der Jagt, Richard H. ;
Cohen, Philip ;
Herst, Jordan A. ;
Tulpule, Anil ;
Schwartzberg, Lee S. ;
Lemieux, Bernard ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (27) :4473-4479
[9]  
Rummel M.J., 2009, Blood, V114
[10]   Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma [J].
Rummel, MJ ;
Al-Batran, SE ;
Kim, SZ ;
Welslau, M ;
Hecker, R ;
Kofahl-Krause, D ;
Josten, KM ;
Dürk, H ;
Rost, A ;
Neise, M ;
von Grünhagen, U ;
Chow, KU ;
Hansmann, ML ;
Hoelzer, D ;
Mitrou, PS .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3383-3389
1